|
|
Article: New Pseudomonas aeruginosa therapy research from R. Dal Negro and colleagues discussed.(Report)
- Article from:
- Biotech Week
- Article date:
- January 28, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Data detailed in 'Tobramycin Nebulizer Solution in severe COPD patients colonized with Pseudomonas aeruginosa: effects on bronchial Inflammation' have been presented. "Airway colonization with Pseudomonas aeruginosa is frequent in severe chronic obstructive pulmonary disease (COPD) and may lead to progressive inflammatory damage. Inhaled Tobramycin Nebulizer Solution (TNS; a preservative-free formulation) is an effective therapy in chronic P aeruginosa infection in cystic fibrosis and bronchiectasis," scientists writing in the journal Advances In Therapy report (see also Pseudomonas aeruginosa Therapy).
"In this study we aimed to investigate the effects of a TNS ...